Physician profile
Heidi Meyer
NPI 1083801989
$12,101.86
in general payments reported to CMS, 2019-2025
18 companies · $9,686 in 2025
The $9,686 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $512 · 2022: $430 · 2023: $533 · 2024: $941 · 2025: $9,686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,363 · Food and Beverage: $2,975 · Consulting Fee: $675 · Travel and Lodging: $148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,362.50 |
| Food and Beverage | $2,974.84 |
| Consulting Fee | $675.00 |
| Travel and Lodging | $147.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $6,115.56 | 2021-2025 | |
| Pfizer INC. | $4,444.27 | 2023-2025 | |
| Lundbeck LLC | $391.76 | 2023-2025 | Vyepti |
| Teva Pharmaceuticals USA, INC. | $204.11 | 2021-2025 | Ajovy |
| Boston Scientific Corporation | $169.31 | 2021-2025 | General - Pain Management |
| Lilly USA, LLC | $168.45 | 2021-2024 | Emgality, Reyvow |
| Amgen INC. | $144.18 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $111.40 | 2021 | |
| Axsome Therapeutics, INC. | $80.51 | 2025 | Symbravo |
| Impel Pharmaceuticals INC. | $78.60 | 2023 | Trudhesa |
| Biohaven Pharmaceutical Holding Company Ltd. | $51.75 | 2022 | |
| Currax Pharmaceuticals LLC | $29.09 | 2021 | |
| Impel Pharmaceuticals LLC | $28.72 | 2024 | Trudhesa |
| Upsher-Smith Laboratories LLC | $19.74 | 2021 | |
| Brainscope Company, INC. | $17.98 | 2023 | Brainscope One |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $17.44 | 2022 | |
| Arbor Pharmaceuticals, INC. | $17.30 | 2021 | |
| Collegium Pharmaceutical, INC. | $11.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.